Prevalence of Helicobacter pylori genotypes (vacA, cagA, cagE and virB11) in gastric cancer in Brazilian's patients: An association with histopathological parameters

Cancer Epidemiology

Volumn 35, Issue 5, 2011, Pages

  Lima, Valeska Portela ^a   Silva Fernandes, Isabelle Joyce de Lima ^a   Alves, Markênia Kélia Santos ^a   Rabenhorst, Silvia Helena Barem ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

CagA; CagE and virB11; Gastric cancer; Helicobacter pylori; VacA

Indexed keywords

BACTERIAL PROTEIN; CAGA PROTEIN; CAGE PROTEIN; UNCLASSIFIED DRUG; VACUOLATING TOXIN; VIRB11 PROTEIN;

ADULT; AGED; ARTICLE; BACTERIAL GENE; BRAZIL; CANCER GRADING; CANCER STAGING; CANCER TISSUE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BRAZIL; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PREVALENCE; PROGNOSIS; STOMACH NEOPLASMS; VIRULENCE FACTORS; YOUNG ADULT;

EID: 80052955506     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2011.02.017     Document Type: Article

References (64)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
2. Konturek P.C., Konturek S.J., Brzozowski T. Gastric cancer and Helicobacter pylori infection. J Physiol Pharmacol 2006, 57:51-65.
3. BRASIL. Ministério da Saúde. Instituto Nacional do Cancer. Coordenação de Prevenção e Vigilância. Estimativas 2008: Incidência de Câncer no Brasil, Rio de Janeiro: INCA, 2007.
4. Wang S.J., Emery R., Fuller C.D., Kim J.S., Sittig D.F., Thomas C.R. Conditional survival in gastric cancer: a SEER database analysis. Gastric Cancer 2007, 10(3):153-158.
5. Laurèn P. Two Histological main types of Gastric Carcinima: diffuse and so-called intestinal-type carcinoma. Acta Path Microbiol Scand 1965, 64:31-49.
6. Werner M., Becker K.F., Keller G., Höfler H. Gastric adenocarcinoma: pathomorphology and molecular pathology. J Cancer Res Clin Oncol 2001, 127:207-216.
7. van der Woude C.J., Kleibeuker J.H., Tiebosch A.T., Homan M., Beuving A., Jansen P.L., et al. Diffuse and intestinal type gastric carcinomas differ in their expression of apoptosis related proteins. J Clin Pathol 2003, 56:699-702.
8. Wen S., Moss S.F. Helicobacter pylori virulence factors in gastric carcinogenesis. Cancer Lett 2009, 282:1-8.
9. Huang J.Q., Sridhar S., Chen Y., Hunt R.H. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998, 114:1169-1179.
10. Go M.F., Kapur V., Graham D.Y., Musser J.M. Population genetic analysis of Helicobacter pylori by multilocus enzyme electrophoresis: extensive allelic diversity and recombinational population structure. J Bacteriol 1996, 178:3934-3938.
11. Kuipers E.J., Pérez-Pérez G.I., Meuwissen S.G., Blaser M.J. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 1995, 87:1777-1780.
12. Censini S., Lange C., Xiang Z., Crabtree J.E., Ghiara P., Borodovsky, et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996, 93:14648-14653.
13. Blaser M.J., Atherton J.C. Helicobacter pylori persistence: biology and disease. J Clin Invest 2004, 113:321-333.
14. Molinari M., Galli C., de Bernard M., Noris N., Ruysschaert J.M., Rappuoli R., et al. The acid activation of Helicobacter pylori toxin VacA: structural and membrane binding studies. Biochem Biophys Res Commun 1998, 248:334-340.
15. Gebert B., Fischer W., Weiss E., Hoffmann R., Haas R. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 2003, 301:1099-1102.
16. Zheng P.Y., Jones N.L. Helicobacter pylori strains expressing the vacuolating cytotoxin interrupt phagosome maturation in macrophages by recruiting and retaining TACO (coronin 1) protein. Cell Microbiol 2003, 5:25-40.
17. Atherton J.C., Cao P., Peek R.M., Tummuru M.K., Blaser M.J., Cover T.L. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995, 270:17771-17777.
18. Odenbreit S., Püls J., Sedlmaier B., Gerland E., Fischer W., Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000, 287:1497-1500.
19. Higashi H., Tsutsumi R., Fujita A. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci USA 2002, 99:14428-14433.
20. Selbach M., Moese S., Meyer T.F., Backert S. Functional analysis of the Helicobacter pylori cag pathogenicity island reveals both VirD4-CagA-dependent and VirD4-CagA-independent mechanisms. Infect Immun 2002, 70:665-671.
21. Tummuru M.K., Sharma S.A., Blaser M.J. Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol Microbiol 1995, 18:867-876.
22. Owen R.J. Molecular epidemiology of Helicobacter pylori in England: prevalence of cag pathogenicity island markers and IS605 presence in relation to patient age and severity of gastric disease. FEMS Immunol Med Microbiol 2001, 30:65-71.
23. Sozzi M., Tomasini M.L., Vindigni C., Zanussi S., Tedeschi R., Basaglia G., et al. Heterogeneity of cag genotypes and clinical outcome of Helicobacter pylori infection. J Lab Clin Med 2005, 146:262-270.
24. Krause S., Pansegrau W., Lurz R., de la Cruz F., Lanka E. Enzymology of type IV macromolecule secretion systems: the conjugative transfer regions of plasmids RP4 and R388 and the cag pathogenicity island of Helicobacter pylori encode structurally and functionally related nucleoside triphosphate hydrolases. J Bacteriol 2000, 182:2761-2770.
25. Backert S., Müller E.C., Jungblut P.R., Meyer T.F. Tyrosine phosphorylation patterns and size modification of the Helicobacter pylori CagA protein after translocation into gastric epithelial cells. Proteomics 2001, 1:608-617.
26. Blaser M.J., Perez-Perez G.I., Kleanthous H., Cover T.L., Peek R.M., Chyou P.H., et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995, 55:2111-2115.
27. De Gusmão V.R., Nogueira Mendes E., De Magalhães Queiroz D.M., Aguira Rocha G., Camargos Rocha A.M., Ramadan Ashour A.A., et al. VacA genotypes in Helicobacter pylori strains isolated from children with and without duodenal ulcer in Brazil. J Clin Microbiol 2000, 38:2853-2857.
28. Ashour A.A., Magalhães P.P., Mendes E.N., Collares G.B., de Gusmão V.R., Queiroz D.M., et al. Distribution of vacA genotypes in Helicobacter pylori strains isolated from Brazilian adult patients with gastritis, duodenal ulcer or gastric carcinoma. FEMS Immunol Med Microbiol 2002, 33:173-178.
29. Godoy A.P., Ribeiro M.L., Benvengo Y.H., Vitiello L., Miranda Mde C., Mendonça S., et al. Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates. BMC Gastroenterol 2003, 11:3-20.
30. Ribeiro M.L., Godoy A.P., Benvengo Y.H., Mendonça S., Pedrazzoli J. Clinical relevance of the cagA, vacA and iceA genotypes of Helicobacter pylori in Brazilian clinical isolates. FEMS Immunol Med Microbiol 2003, 36:181-185.
31. Gatti L.L., Fagundes e Souza E.K., Leite K.R., Bastos E.L., Vicentini L.R., Silva L.C., et al. cagA vacA alelles and babA2 genotypes of Helicobacter pylori associated with gastric disease in Brazilian adult patients. Diagn Microbiol Infect Dis 2005, 51:231-235.
32. Martins L.C., Corvelo T.C., Demachki S., Araujo M.T., Assumpção M.B., Vilar S.C., et al. Clinical and pathological importance of vacA allele heterogeneity and cagA status in peptic ulcer disease in patients from North Brazil. Mem Inst Oswaldo Cruz 2005, 100:875-881.
33. Módena J.L., Acrani G.O., Micas A.F., Castro M., Silveira W.D., Módena J.L., et al. Correlation between Helicobacter pylori infection, gastric diseases and life habits among patients treated at a university hospital in Southeast Brazil. Braz J Infect Dis 2007, 11:89-95.
34. Buruk F., Berberoglu U., Pak I., Aksaz E., Celen O. Gastric cancer and Helicobacter pylori infection. Br J Surg 1993, 80(3):378-379.
35. Smith M.G., Hold G.L., Tahara E., El-Omar E.M. Cellular and molecular aspects of gastric cancer. World J Gastroenterol 2006, 21:2979-2990.
36. Nomura A., Stemmermann G.N., Chyou P.H., Kato I., Perez-Perez G.I., Blaser M.J. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991, 325:1132-1136.
37. Hansson L.E., Engstrand L., Nyrén O., Evans D.J.Jr., Lindgren A., Bergström R., et al. Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology 1993, 105:1098-1103.
38. Foster G.D., Twell D. Plant Gene Isolation Principles and Practice 1996, John Wiley & Sons Ltd., England, p. 426.
39. Lage A.P., Godfroid E., Fauconnier A., Burette A., Butzler J.P., Bollen A., et al. Diagnosis of Helicobacter pylori infection by PCR: comparison with other invasive techniques and detection of cagA gene in gastric biopsy specimens. J Clin Microbiol 1995, 33:2752-2756.
40. Domingo D., Alarcón T., Prieto N., Sánchez I., López-Brea M. cagA and vacA status of Spanish Helicobacter pylori clinical isolates. J Clin Microbiol 1999, 37:2113-2114.
41. Uemura N., Okamoto S., Yamamoto S., Matsumura N., Yamaguchi S., Yamakido M., et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001, 345:784-789.
42. Blaser M.J., Parsonnet J. Parasitism by the " slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 1994, 94:4-8.
43. Graham D.Y., Malaty H.M., Go M.F. Are there susceptible hosts to Helicobacter pylori infection?. Scand J Gastroenterol Suppl 1994, 205:6-10.
44. Fallone C.A., Barkun A.N., Göttke M.U., Beech R.N. A review of the possible bacterial determinants of clinical outcome in Helicobacter pylori infection. Can J Microbiol 1998, 44:201-210.
45. Basso D., Navaglia F., Brigato L., et al. Analysis of Helicobacter pylori vacA and cagA genotypes and serum antibody profile in benign and malignant gastroduodenal diseases. Gut 1998, 43:182-186.
46. van Doorn L.J., Figueiredo C., Sanna R., Plaisier A., Schneeberger P., de Boer W., et al. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 1998, 115:58-66.
47. Nogueira C., Figueiredo C., Carneiro F., Gomes A.T., Barreira R., Figueira P., et al. Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol 2001, 158:647-654.
48. Saribasak H., Salih B.A., Yamaoka Y., Sander E. Analysis of Helicobacter pylori genotypes and correlation with clinical outcome in Turkey. J Clin Microbiol 2004, 42(4):1648-1651.
49. Letley D.P., Rhead J.L., Twells R.J., Dove B., Atherton J.C. Determinants of non-toxicity in the gastric pathogen Helicobacter pylori. J Biol Chem 2003, 278:26734-26741.
50. Yu F.J., Wu D.C., Kuo C.H., et al. Diagnosis of Helicobacter pylori infection by stool antigen test in southern Taiwan. Kaohsiung J Med Sci 2001, 17:344-350.
51. Chomvarin C., Namwat W., Chaicumpar K., Mairiang P., Sangchan A., Sripa B., et al. Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA and babA2 genotypes in Thai dyspeptic patients. Int J Infect Dis 2008, 2:30-36.
52. Alarcón T., Domingo D., Martinez M.J., López-Brea M. cagA gene and vacA alleles in Spanish Helicobacter pylori clinical isolates from patients of different ages. FEMS Immunol Med Microbiol 1999, 24:215-219.
53. Nimri L.F., Matalka I., Bani Hani K., Ibrahim M. Helicobacter pylori genotypes identified in gastric biopsy specimens from Jordanian patients. BMC Gastroenterol 2006, 4(6:):27.
54. Evans D.G., Queiroz D.M., Mendes E.N., Evans D.J. Helicobacter pylori cagA status and s and m alleles of vacA in isolates from individuals with a variety of H. pylori-associated gastric diseases. J Clin Microbiol 1998, 36:3435-3437.
55. Thomazini C.M., Pinheiro N.A., Pardini M.I., Naresse L.E., Rodrigues M.A.M. Helicobacter pylori and gastric cancer: distribution of cagA and vacA genotypes in patients with gastric carcinoma. J. Bras Patol Med Lab 2006, 42:25-30.
56. Yokoyama K., Higashi H., Ishikawa S., et al. Functional antagonism between Helicobacter pylori CagA and vacuolating toxin VacA in control of the NFAT signaling pathway in gastric epithelial cells. Proc Natl Acad Sci USA 2005, 102:9661-9666.
57. Ikenoue T., Maeda S., Ogura K., Akanuma M., Mitsuno Y., Imai Y., et al. Determination of Helicobacter pylori virulence by simple gene analysis of the cag pathogenicity island. Clin Diagn Lab Immunol 2001, 8:181-186.
58. Kauser F., Khan A.A., Hussain M.A., Carroll I.M., Ahmad N., Tiwari S., et al. The cag pathogenicity island of Helicobacter pylori is disrupted in the majority of patient isolates from different human populations. J Clin Microbiol 2004, 42:5302-5308.
59. Ali M., Khan A.A., Tiwari S.K., Ahmed N., Rao L.V., Habibullah C.M. Association between cag-pathogenicity island in Helicobacter pylori isolates from peptic ulcer, gastric carcinoma, and non-ulcer dyspepsia subjects with histological changes. World J Gastroenterol 2005, 11:6815-6822.
60. Erzin Y., Koksal V., Altun S., et al. Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA, babA2 genotypes and correlation with clinical outcome in Turkish patients with dyspepsia. Helicobacter 2006, 11:574-580.
61. Tomasini M.L., Zanussi S., Sozzi M., Tedeschi R., Basaglia G., De Paoli P. Heterogeneity of cag genotypes in Helicobacter pylori isolates from human biopsy specimens. J Clin Microbiol 2003, 41:976-980.
62. Palestro G., Pellicano R., Fronda G.R., et al. Prevalence of Helicobacter pylori infection and intestinal metaplasia in subjects who had undergone surgery for gastric adenocarcinoma in Northwest Italy. World J Gastroenterol 2005, 11:7131-7135.
63. Kuroda T., Ito M., Wada Y., Kitadai Y., Tanaka S., Yoshida K., et al. Presence of poorly differentiated component correlated with submucosal invasion in the early diffuse-type gastric cancer. Hepatogastroenterology 2008, 55:2264-2268.
64. Vieth M., Stolte M. Elevated risk for gastric adenocarcinoma can be predicted from histomorphology. World J Gastroenterol 2006, 12:6109-6114.